These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 602344)

  • 1. Studies on the chemical composition and biological properties of transfer factor.
    Krohn K; Uotila A; Väisänen J; Gröhn P
    Z Immunitatsforsch Immunobiol; 1977 Dec; 153(5):395-411. PubMed ID: 602344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects.
    Wilson GB; Fudenberg HH
    J Lab Clin Med; 1979 May; 93(5):819-37. PubMed ID: 429877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the chemical nature of dialysable transfer factor. Comparison of human leukocyte dialysate and dialysates derived from human serum and from mammalian lymphoid and non-lymphoid organs.
    Uotila A
    Immunobiology; 1980 Jan; 156(4-5):353-63. PubMed ID: 7372348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human transfer factor: fractionation and biologic activity.
    Burger DR; Vandenbark AA; Daves D; Anderson WA; Vetto RM; Finke P
    J Immunol; 1976 Sep; 117(3):789-96. PubMed ID: 134121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor.
    O'Dorisio MS; Neidhart JA; Daniel FB; Balcerzak SP; LoBuglio AF
    Cell Immunol; 1976 May; 23(2):191-202. PubMed ID: 1277303
    [No Abstract]   [Full Text] [Related]  

  • 6. Fractionation studies on human leucocyte dialyzates. Demonstration of three components with transfer factor activity.
    Krohn K; Gröhn P; Horsmanheimo M; Virolainen M
    Med Biol; 1976 Dec; 54(5):334-40. PubMed ID: 994567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Uracil in transfer factor.
    Krohn KJ; Uotila A; Gröhn P; Väisänen J
    Lancet; 1975 Dec; 2(7946):1209. PubMed ID: 53691
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfer factor (TFd). Part I. Some physicochemical data.
    Komorowska-Rycerz A; Szczypiorska D; Izdebska-Szymona K; Kociński W; Zarzycka A; Rzucidło L
    Mater Med Pol; 1979; 11(4):317-9. PubMed ID: 553982
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation of beta2-microglobulin from transfer factor in dialyzable leukocyte extracts.
    Nékám K; Kelemen GS; Varró R; Fekete B; Láng I; Kalmár L; Gergely P; Petrányi G
    Allerg Immunol (Leipz); 1978; 24(4):254-8. PubMed ID: 84525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
    Khan A; Thometz D; Garrison O; Hill JM
    Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography.
    Vandenbark AA; Burger DR; Dreyer DL; Daves GD; Vetto RM
    J Immunol; 1977 Feb; 118(2):636-41. PubMed ID: 839073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different fractions of dialyzable leukocyte extract--transfer factor--on the chemiluminescence of human phagocytes.
    Sipka S; Schröder I; Brazsnikova NA
    Allergol Immunopathol (Madr); 1987; 15(3):143-4. PubMed ID: 3661353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification and significance of hypoxanthine in dialyzable transfer factor.
    Kirkpatrick CH; Robinson LB; Smith TK
    Cell Immunol; 1976 Jun; 24(2):230-40. PubMed ID: 181148
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transfer factor. Properties and possible therapeutic applications (author's transl)].
    Grob PJ; Reymond JF; Häcki MA; Frey-Wettstein M
    MMW Munch Med Wochenschr; 1975 Mar; 117(13):517-24. PubMed ID: 805916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro determination of effects of dialyzable leukocyte extracts containing transfer factor activity.
    Schroder I; Rovensky J
    Allergol Immunopathol (Madr); 1982; 10(3):171-6. PubMed ID: 7148610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component in TFg, a precursor of Tx, as hypoxanthine.
    Wilson GB; Welch TM; Knapp DR; Horsmanheimo A; Fudenberg HH
    Clin Immunol Immunopathol; 1977 Nov; 8(3):551-68. PubMed ID: 912950
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transfer factor in the treatment of children with disorders of cellular immunity].
    Misarová Z; Kynclová S; Nováková J; Kubícková J; Eichlerová H
    Cesk Pediatr; 1985 Jun; 40(6):346-9. PubMed ID: 4017090
    [No Abstract]   [Full Text] [Related]  

  • 19. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of transfer factor in adjuvant diseases in rats.
    Grimová J; Pokorná D; Schröder I; Rovenský J; Pekárek J; Lackovic V
    Allergol Immunopathol (Madr); 1985; 13(1):17-21. PubMed ID: 2408454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.